|
|
Article: Panbio Purchases Intellectual Property from Corixa for Detecting Tick Borne Diseases.
- Article from:
- Business Wire
- Article date:
- April 12, 2005
|
Copyright informationCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SEATTLE & BRISBANE, Australia -- Australian-based international medical diagnostics company Panbio Limited, listed on the Australian Stock Exchange (ASX:PBO) and Corixa Corporation (Nasdaq:CRXA), a developer of immunotherapeutics, announced today that Panbio has signed an agreement to acquire intellectual property from Corixa that would assist in the development of new assays for the diagnosis of the tick borne diseases, Ehrlichiosis and Babesiosis.
Under terms of the agreement, Corixa will receive an undisclosed up-front payment, annual maintenance payments and royalties on future product sales. The agreement will also transfer to Panbio a portfolio of unique recombinant ...